Oxford BioDynamics Plc / Fundamentals
Income statement
- Net revenue
€1.32M - Cost of goods sold
€17.47M - Gross profit
-€16.15M - SG&A expenses
€9.09M - R&D expenses
€1.81M - EBITDA
-€22.59M - D&A
€3.26M - EBIT
-€27.04M - Interest expenses
€848.12K - EBT
-€26.93M - Tax expenses
-€1.12M - Net income
-€25.80M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€6.39M - Changes in working capital
-€1.51M - Operating cash flow
-€21.58M - Capex
€1.18M - Other investing cash flow
€2.79M - Net investing cash flow
-€2.63M - Total cash dividends paid
€0.00 - Issuance of common stock
€26.78M - Debt repayment
€0.00 - Other financing cash flow
-€1.55M - Net financing cash flow
€25.24M - Foreign exchange effects
-€19.59K - Net change in cash
€245.45K - Cash at end of period
€2.11M - Free cash flow
-€20.40M
Balance sheet
- Cash and cash equivalents
€2.11M - Cash and short-term investments
€3.26M - Total receivables
€1.60M - Inventory
€369.90K - Other current assets
€591.15K - Total current assets
€5.81M - Property, plant & equipment
€6.58M - Goodwill
€0.00 - Intangible assets
€1.56M - Long-term investments
€0.00 - Other non-current assets
€0.00 - Total non-current assets
€8.14M - Total assets
€13.95M - Accounts payable
€1.10M - Short-term debt
€1.21M - Other current liabilities
€649.92K - Total current liabilities
€2.95M - Long-term debt
€5.41M - Deferred tax liabilities
€8.07K - Other non-current liabilities
€560.04K - Total non-current liabilities
€5.98M - Total liabilities
€8.93M - Common stock
€3.59M - Retained earnings
-€48.54M - Other equity
€0.00 - Total equity
€5.02M - Total liabilities and shareholders' equity
€13.95M
Company information
- Market capitalization
€8.31M - Employees
51 - Enterprise Value
€10.91M
Company ratios
- Gross margin
-
-1,222.7% Much worse than peer group: -94.1% - EBITDA margin
-
-1,710.6% Much worse than peer group: -1,534.8% - EBIT margin
-
-2,047.9% Much worse than peer group: -1,477.0% - EBT margin
-
-2,039.0% Much worse than peer group: -1,526.1% - Net margin
-
-1,954.0% Much worse than peer group: -1,292.8% - ROE
-
-513.8% Much worse than peer group: -33.2% - ROA
-
-184.9% Much worse than peer group: -95.1% - Asset turnover
-
9.5% Worse than peer group: 26.2% - FCF margin
-
-1,722.9% Much worse than peer group: -1,201.1% - FCF yield
-273.8% - Efficiency ratio
1,810.6% - Net sales per employee
-
€25.89K - Net income per employee
-
-€505.97K